Nonviral Delivery Systems for Cancer Gene Therapy: Strategies and Challenges

Author(s): Gayong Shim*, Dongyoon Kim, Quoc-Viet Le, Gyu Thae Park, Taekhyun Kwon, Yu-Kyoung Oh*

Journal Name: Current Gene Therapy

Volume 18 , Issue 1 , 2018

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Gene therapy has been receiving widespread attention due to its unique advantage in regulating the expression of specific target genes. In the field of cancer gene therapy, modulation of gene expression has been shown to decrease oncogenic factors in cancer cells or increase immune responses against cancer. Due to the macromolecular size and highly negative physicochemical features of plasmid DNA, efficient delivery systems are an essential ingredient for successful gene therapy. To date, a variety of nanostructures and materials have been studied as nonviral gene delivery systems. In this review, we will cover nonviral delivery strategies for cancer gene therapy, with a focus on target cancer genes and delivery materials. Moreover, we will address current challenges and perspectives for nonviral delivery-based cancer gene therapeutics.

Keywords: Cancer gene therapy, Nonviral gene therapy, Nonviral delivery, Target cancer gene, Macromolecular, DNA.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 03 May, 2018
Page: [3 - 20]
Pages: 18
DOI: 10.2174/1566523218666180119121949
Price: $65

Article Metrics

PDF: 116
HTML: 32